Kamdar Kim P. — SEC Form 4 filings
SEC reporting owner CIK 1535065. 7 Form 4 filings on record with FilingPulse; latest filed 2026-07-14.
Transaction summary — filings shown
Covers all 7 filings on record, filed 2023-12-22 to 2026-07-14. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): none reported.
- Open-market sales (code S, non-derivative): 1 leg across 1 filing — 10 shares, $6 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 18.
- Largest priced transaction: sale of 10 shares @ $0.62 ($6) in Evofem Biosciences, Inc., filed 2023-12-22.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Evofem Biosciences, Inc. (EVFM) | Director | 1 | — | 1 leg · 10 sh · $6 | — |
| SERA PROGNOSTICS, INC. (SERA) | Director | 4 | — | — | 10 |
| Singular Genomics Systems, Inc. (OMIC) | Director | 2 | — | — | 8 |
Form 4 filings — Kamdar Kim P.
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-07-14 | 4 | SERA PROGNOSTICS, INC. (SERA) | Grant/award (A): 22,426 @ $0 · Grant/award (A): 3,421 @ $0 · Grant/award (A): 34,494 (derivative) @ $0 · Grant/award (A): 5,263 (derivative) @ $0 | EDGAR |
| 2026-02-04 | 4 | SERA PROGNOSTICS, INC. (SERA) | Other (J): 30,920 @ $0 · Other (J): 3,231 @ $0 | EDGAR |
| 2025-06-06 | 4 | SERA PROGNOSTICS, INC. (SERA) | Grant/award (A): 15,596 @ $0 · Grant/award (A): 25,000 (derivative) @ $0 | EDGAR |
| 2025-02-25 | 4 | Singular Genomics Systems, Inc. (OMIC) | Disposition to issuer (D): 15,000 · Disposition to issuer (D): 3,763,985 · Disposition to issuer (D): 15,000 · Disposition to issuer (D): 666 (derivative) @ $0 · Disposition to issuer (D): 1,541 (derivative) @ $0 · Disposition to issuer (D): 2,466 (derivative) @ $0 · +1 more | EDGAR |
| 2024-06-07 | 4 | SERA PROGNOSTICS, INC. (SERA) | Grant/award (A): 7,117 @ $0 · Grant/award (A): 10,549 (derivative) @ $0 | EDGAR |
| 2024-05-31 | 4 | Singular Genomics Systems, Inc. (OMIC) | Grant/award (A): 74,000 (derivative) @ $0 | EDGAR |
| 2023-12-22 | 4 | Evofem Biosciences, Inc. (EVFM) | Sale (S): 10 @ $0.62 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2023-12-20 and is expanding backward through EDGAR history — earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
Need this as JSON?
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1535065 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. API docs →